CyTOF and Helios Publications

CyTOF: We have mass appeal. The technology backed by 1,000+ publications.

CyTOF® is the only high-parameter single-cell analysis system vetted by more than 1,000 publications. Covering a wide spectrum of diseases and research applications, this collection of studies demonstrates the versatility and proven performance of mass cytometry for translational and clinical research around the world.

Explore the publications by research area using the links to the right.


Browse our complete catalog of over 1,000 CyTOF related publications to see how Helios™ and mass cytometry empower researchers to make breakthrough discoveries in basic, translational and clinical research.
Download Now

Mass Cytometry Publications Trending Now

Take a look at the issues of Mass Cytometry Publications Trending Now, a quarterly anthology series covering the most recent and impactful publications that help expand our understanding of human health and disease

July 2021: On high-parameter cytometry
April 2021: On Immuno-Oncology
January 2021: On cancer vaccine development.
November 2020: On recent applications of mass cytometry to vaccine development for infectious diseases.
July 2020: On use of mass cytometry in COVID-19 disease research studies to date
March 2020: On high-dimensional functional assessment of health vs. disease
December 2019: On use of mass cytometry in clinical trials
September 2019: On key publications from 2019